Retraction
MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
Paper Information
Record ID:
37790
Author(s):
Journal:
Publication Date:
October 17, 2017
Retraction Date:
May 31, 2022
(3.5 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ol.2022.13357Additional Notes:
see also: https://pubpeer.com/publications/A8AC8045BE16E162A9443B52CF5E53
Citations (28)
28
Total Citations2
Post-Retraction(7.1%)
26
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
142
Days since retraction (latest)
FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway
Zhijun Shen, Chen Chen
Protein and Peptide Letters
Published: Oct 2022
12 citations
12 citations
142 days after retraction
BLNIMDA: identifying miRNA-disease associations based on weighted bi-level network
Junliang Shang, Yi Yang, Feng Li et al. (6 authors)
BMC Genomics
Open Access
Published: Oct 2022
3 citations
3 citations
127 days after retraction
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
Maria Papaioannou, Angeliki Chorti, Anthoula Chatzikyriakidou et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Feb 2022
22 citations
22 citations
117 days before retraction
Epigenetic signature associated with thyroid cancer progression and metastasis
Hong Zhang, Hongliang Duan, Sen Wang et al. (6 authors)
Seminars in Cancer Biology
Published: Mar 2021
15 citations
15 citations
430 days before retraction
Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa, Klaudia Klicka, Paweł Włodarski
Cancers
Open Access
Published: Dec 2020
35 citations
35 citations
537 days before retraction
CCNA1 gene as a potential diagnostic marker in papillary thyroid cancer
Raissa Monteiro da Silva, Joyce Nascimento Santos, Miyuki Uno et al. (7 authors)
Acta Histochemica
Published: Sep 2020
8 citations
8 citations
608 days before retraction
The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing Fibronectin-1
Mingxiang Cao, Di Xiao, Xubei Ding
Bioscience Biotechnology and Biochemistry
Published: Sep 2020
11 citations
11 citations
620 days before retraction
MicroRNA‑3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer
Fei Shen, Xiao‐Xiong Gan, Xingyan Deng et al. (8 authors)
Oncology Letters
Open Access
Published: Sep 2020
10 citations
10 citations
628 days before retraction
Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers
Neda Khalili, Masoud Nouri‐Vaskeh, Zahra Hasanpour Segherlou et al. (7 authors)
Life Sciences
Published: Jun 2020
24 citations
24 citations
728 days before retraction
MiR-451a restrains the growth and metastatic phenotypes of papillary thyroid carcinoma cells via inhibiting ZEB1
Qiong Wang, Jing Shang, Yun Zhang et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Apr 2020
22 citations
22 citations
768 days before retraction
An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer
Wanwan Yi, Jin Liu, Shuping Qu et al. (5 authors)
Technology in Cancer Research & Treatment
Open Access
Published: Jan 2020
9 citations
9 citations
881 days before retraction
BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis
Cong Zhang, Chunrui Bo, Lunhua Guo et al. (6 authors)
World Journal of Surgical Oncology
Open Access
Published: Dec 2019
15 citations
15 citations
912 days before retraction
miR‐98‐5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase‐3 by HMGA2
Kai Qiu, Qingji Xie, Shan Jiang et al. (4 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Oct 2019
28 citations
28 citations
943 days before retraction
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine
Alessandra Jordano Conforte, Jack A. Tuszyński, Fabrício Alves Barbosa da Silva et al. (4 authors)
Frontiers in Genetics
Open Access
Published: Oct 2019
24 citations
24 citations
953 days before retraction
microRNA‐599 promotes apoptosis and represses proliferation and epithelial‐mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2‐depentent Notch signaling pathway
Wang Duo-ping, Xiao‐Zhun Tang, Quankun Liang et al. (6 authors)
Journal of Cellular Physiology
Published: Sep 2019
45 citations
45 citations
975 days before retraction
Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing
Cristina Montero‐Conde, Osvaldo Graña‐Castro, Guillermo Martín‐Serrano et al. (32 authors)
International Journal of Cancer
Open Access
Published: Aug 2019
36 citations
36 citations
1023 days before retraction
MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL
Robert K. Nam, Tania Benatar, Christopher J.D. Wallis et al. (7 authors)
The Prostate
Published: Jul 2019
36 citations
36 citations
1063 days before retraction
Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme
Sanu K. Shaji, Damu Sunilkumar, N. Mahalakshmi et al. (5 authors)
Oncology Letters
Open Access
Published: Jun 2019
13 citations
13 citations
1072 days before retraction
MiR-376c-3p targets heparin-binding EGF-like growth factor (HBEGF) to inhibit proliferation and invasion in medullary thyroid carcinoma cells
Ning Bai, Deqiang Hou, ChunPu Mao et al. (6 authors)
Archives of Medical Science
Open Access
Published: Jun 2019
4 citations
4 citations
1090 days before retraction
MicroRNA‑432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion
Shanzong Wang, Baohong Gao, Hailin Yang et al. (6 authors)
Oncology Letters
Open Access
Published: May 2019
53 citations
53 citations
1100 days before retraction
MiR-345-5p inhibits tumorigenesis of papillary thyroid carcinoma by targeting SETD7
Ming Zhao, Kejing Wang, Jinbiao Shang et al. (6 authors)
Archives of Medical Science
Open Access
Published: Apr 2019
14 citations
14 citations
1141 days before retraction
The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis
You Zhou, Ling Yin, Hui Li et al. (5 authors)
Cancer Biology & Therapy
Open Access
Published: Apr 2019
48 citations
48 citations
1145 days before retraction
miRNA‑766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4
Weirong Chen, Gaoyang Cai, Ziqun Liao et al. (6 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Mar 2019
32 citations
32 citations
1162 days before retraction
Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes
Kelly Regan, Jielin Xu, Mallory J. DiVincenzo et al. (9 authors)
npj Systems Biology and Applications
Open Access
Published: Feb 2019
49 citations
49 citations
1190 days before retraction
Prognostic value of a two‐microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions
Tong Liu, Xin You, Jing Sui et al. (12 authors)
Journal of Cellular Biochemistry
Published: Nov 2018
19 citations
19 citations
1306 days before retraction
MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
Jianjie Zhao, Zhirong Li, Yi Chen et al. (10 authors)
International Journal of Oncology
Open Access
Published: Nov 2018
27 citations
27 citations
1307 days before retraction
The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications
Wei-ning Cen, Jinshu Pang, Jiacheng Huang et al. (10 authors)
Pathology - Research and Practice
Published: Sep 2018
20 citations
20 citations
1356 days before retraction
miR‑590‑5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5
Wei Cai, Yong Xu, Jian Yin et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Jun 2018
20 citations
20 citations
1446 days before retraction
Quick Stats
Total Citations:
28
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025